Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.220
-0.010 (-0.81%)
Jan 27, 2026, 4:00 PM EST - Market closed
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $27.31 million as of January 28, 2026. Its market cap has decreased by -49.39% in one year.
Market Cap
27.31M
Enterprise Value
-40.50M
1-Year Change
-49.39%
Ranking
Category
Stock Price
$1.22
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $27.31M, a decrease of -92.33%. That is a compound annual growth rate of -75.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 27.31M | 1.67% |
| Dec 31, 2025 | 26.86M | -58.46% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lixte Biotechnology Holdings | 29.71M |
| Barinthus Biotherapeutics | 29.10M |
| Serina Therapeutics | 29.01M |
| Jupiter Neurosciences | 28.40M |
| Rallybio | 28.33M |
| IGC Pharma | 27.84M |
| Senti Biosciences | 27.61M |
| NeuroSense Therapeutics | 27.43M |